MktsMarkets

Iovance Biotherapeutics, Inc.
NASDAQ: IOVAKey statistics
IOVA News
Stories mentioning IOVA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 71,430 | 86,771 | 67,455 | 59,952 | 49,324 | 73,694 | 58,555 | 31,106 |
| Cost of Goods Sold | 42,498 | 35,328 | 38,477 | 56,664 | 42,715 | 23,101 | 31,518 | 31,368 |
| Gross Profit | 28,932 | 51,443 | 28,978 | 3,288 | 6,609 | 50,593 | 27,037 | (262.00) |
| Operating Expenses | ||||||||
| Research & Development | 62,487 | 69,768 | 75,174 | 79,363 | 75,965 | 67,325 | 67,036 | 62,084 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (81,043) | (73,460) | (94,901) | (113,774) | (121,221) | (86,576) | (89,066) | (101,914) |
| Interest Income | 1,333 | 1,740 | 1,243 | 4,104 | 3,220 | 9,575 | 4,005 | 3,355 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (79,710) | (71,720) | (93,658) | (109,670) | (118,001) | (77,001) | (85,061) | (98,559) |
| Tax Provision | (665.00) | 184.00 | (2,405) | 1,988 | (1,838) | 1,558 | (1,520) | (1,458) |
| Net Income (Loss) | (79,045) | (71,904) | (91,253) | (111,658) | (116,163) | (78,559) | (83,541) | (97,101) |
| Earnings Per Share (Basic) | (0.19) | (201.41) | (0.25) | (0.33) | (0.36) | (270.89) | (0.28) | (0.34) |
| Earnings Per Share (Diluted) | (0.19) | (0.33) | (0.36) | (270.89) | (0.28) | (0.34) | ||
| Weighted Average Shares Outstanding (Basic) | 419.00 | 357.00 | 364.00 | 335.00 | 323.00 | 290.00 | 303.00 | 285.00 |
| Weighted Average Shares Outstanding (Diluted) | 419.00 | 335.00 | 323.00 | 290.00 | 303.00 | 285.00 | ||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IOVA
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a stock listed on the Nasdaq Stock Market under the ticker symbol IOVA. It last traded at $8.59 (Nov 9, 2026, 12:40 PM ET), up 6.8% on the day. That gives Iovance Biotherapeutics a market capitalisation of $3.7B.
Over the past 52 weeks IOVA has traded between $2.08 and $15.37.
Revenue for the quarter ended Mar 31, 2026 was $71.4M; a net loss of $79.0M. Revenue was up 44.8% from $49.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $71.4M | -$79.0M | -110.7% |
| Dec 31, 2025 | $86.8M | -$71.9M | -82.9% |
| Sep 30, 2025 | $67.5M | -$91.3M | -135.3% |
| Jun 30, 2025 | $60.0M | -$111.7M | -186.2% |
From Iovance Biotherapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…